Azithromycin in Atopic Dermatitis

NCT07713186 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-07-20

No results posted yet for this study

Summary

The study will evaluate the role of adding azithromycin to topical treatment in patients with mild to moderate atopic dermatitis

Conditions

Interventions

DRUG

Betamethasone or tacrolimus ointments

Topical treatment will be applied, Betamethasone or tacrolimus ointments

DRUG

Azithromycin

Azithromycin will be combined with topical treatment

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07713186 on ClinicalTrials.gov